期刊文献+

乳腺癌淋巴结转移与癌组织中白细胞介素-6及受体的关系 被引量:1

Relationship between the expression of interleukin-6,interleukin-6 receptor and lymph node metastasis in breast carcinoma
原文传递
导出
摘要 目的 研究乳腺癌淋巴结转移与活体癌组织中白细胞介素 6(IL 6)及白细胞介素 6受体 (IL 6R)表达的关系。方法 应用病理学诊断方法检查腋淋巴结有无癌细胞转移 ,采用逆转录 聚合酶链反应 (RT PCR)的方法检测乳腺癌组织IL 6、IL 6R的mRNA表达。结果 IL 6组中 ,有腋淋巴结转移的癌组织中IL 6表达率为 47.619% (10 /2 1) ,无转移的为 82 .979% (3 9/4 7) ,差异有非常显著性 (χ2 =9.0 13 ,P <0 .0 1) ;IL 6R组中 ,有淋巴结转移的IL 6R表达率为 3 8.0 95 % (8/2 1) ,无转移的为 89.3 62 % (4 2 /4 7) ,差异有非常显著性 (χ2 =19.60 ,P <0 .0 0 1)。结论 乳腺癌组织中的IL 6及IL Objective To study the relationship between lymph node metastasis and the expression of interleukin-6 (IL-6),interleukin-6 receptor (IL-6R) in breast cancerous tissues.Methods The axillary lymph nodes were examined by pathological method to determine whether metastasis occurred.Reverse transcription-PCR was used to detect the expression of IL-6 and IL-6R mRNA in breast cancerous tissues.Results In the IL-6 group,the rate of IL-6 positive expression with or without axillary lymph node metastasis was 47.619 % (10/21) and 82.979 % (39/47) respectively with the difference being very significant (χ 2=9.013,P<0.01).In the IL-6R group,the rate of IL-6R positive expression with or without axillary lymph node metastasis was 38.095 % (8/21) and 89.362 % (42/47) with the difference being very significant (χ 2=19.60,P<0.001).Conclusion The expression of IL-6 and IL-6R is significantly correlated with lymph node metastasis and prognosis of breast carcinoma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2003年第9期813-814,共2页 Chinese Journal of Experimental Surgery
关键词 乳腺癌 淋巴结转移 癌组织 白细胞介素-6 白细胞介素-6受体 诊断 病理学 淋巴结转移瘤 Breast carcinoma Interleukin-6 Lymph node Metastasis
  • 相关文献

参考文献9

  • 1Kishimoto T, Hirano T. Molecular regulation of B lymphoeytes response. Annu Rev Immunol, 1988, 6 : 485-512.
  • 2Takenawa J, Kaneko Y, Fukumoto M, et al. Enhanced expression of interlukin 6 in primary human renal cell carcinomas. J Natl Cancer Inst,1991, 83 : 1668-1672.
  • 3Chen L, Schulman LM, Revel M. IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells. J Biol Regul Homeeost Agents, 1991, 4:125-136.
  • 4Douglas AM, Goss GA, Sutherland RL, et al. Expression and function of members of the cytokine receptor superfamily on breast cancer cells.Oncogene, 1997,14:661-669.
  • 5Tamm I, Cardinale I, Murphy JS. Decreased adherence of interleukin 6 treated breast cancer cells can lead to separation from neighbors after mitosis. Proc Natl Acad Sci USA, 1991, 88:4414-4418.
  • 6Heinrich PC, Behrmann I, Mueller-Newen G, et al. Interhukin 6-type cytokine signaling through the gp130/JAK/STAT pathway. Biochem J, 1998, 334 : 297-314.
  • 7Basolo F, Fiore L, Fontanini G, et al. Expression and response to Interleukin 6 ( IL-6 ) in human mammary tumors. Cancer Res, 1996, 56 :3318-3322.
  • 8Dvorak HF, Siossat TM, Broun LF, et al. Distribution of vascular permeability factors in tumors:conentration in tumor vessels. J Exp Med, 1991, 174:1275-1278.
  • 9Shiozawa N, Kodama M, Chida T, et al. Recurrent death among early gastric cancer patients: 20 year' s experience. Hepatogastroenterol,1994, 41 : 244-247.

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部